- Home
- QRVO vs ELAN Comparison
QRVO vs ELAN Comparison
Compare QRVO & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QRVO | ELAN |
|---|---|---|
| Founded | 1957 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 12.2B |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | QRVO | ELAN |
|---|---|---|
| Price | $112.21 | $21.81 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 19 | 16 |
| Target Price | ★ $90.17 | $31.00 |
| AVG Volume (30 Days) | 1.2M | ★ 3.9M |
| Earning Date | 11-02-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 524.14 | N/A |
| EPS | ★ 3.62 | 0.22 |
| Revenue | $3,678,517,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | N/A | $8.66 |
| Revenue Next Year | $3.40 | $5.29 |
| P/E Ratio | ★ $32.39 | $102.80 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $75.43 | $19.40 |
| 52 Week High | $121.09 | $27.98 |
Technical Indicators
Market Signals| Indicator | QRVO | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 56.85 | 39.61 |
| Support Level | $77.62 | $21.76 |
| Resistance Level | $121.09 | $25.21 |
| Average True Range (ATR) | 4.44 | 0.64 |
| MACD | -0.76 | -0.01 |
| Stochastic Oscillator | 49.77 | 31.12 |
Price Performance
Historical ComparisonAbout QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of non-smartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.